Validity Evidence for the Use of Automated Neuropsychologic Assessment Metrics As a Screening Tool for Cognitive Impairment in Systemic Lupus Erythematosus.
Oshrat E Tayer-ShifmanRobin GreenDorcas E BeatonLesley RuttanJoan E WitherMaria Carmela TartagliaMahta KakvanSabrina LombardiNicole AndersonJiandong SuDennisse BonillaMoe ZandyMay Y ChoiMarvin J FritzlerZahi ToumaPublished in: Arthritis care & research (2020)
This study provides support for ANAM's discriminative validity for cognitive impairment and utility for cognitive screening in adult SLE. Derived composite indices and cutoffs enhance clinical applicability.